Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimenta...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Physics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphy.2020.565055/full |
id |
doaj-88275246ca1f4bacb94b8d81b66f3077 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nicholas T. Henthorn Nicholas T. Henthorn Olga Sokol Marco Durante Marco Durante Ludovic De Marzi Frederic Pouzoulet Justyna Miszczyk Pawel Olko Sytze Brandenburg Sytze Brandenburg Marc Jan van Goethem Marc Jan van Goethem Lara Barazzuol Lara Barazzuol Makbule Tambas Johannes A. Langendijk Marie Davídková Vladimír Vondráĉek Elisabeth Bodenstein Joerg Pawelke Joerg Pawelke Antony J. Lomax Antony J. Lomax Damien C. Weber Damien C. Weber Damien C. Weber Alexandru Dasu Alexandru Dasu Bo Stenerlöw Per R. Poulsen Brita S. Sørensen Cai Grau Mateusz K. Sitarz Anne-Catherine Heuskin Stephane Lucas John W. Warmenhoven John W. Warmenhoven Michael J. Merchant Michael J. Merchant Ran I. Mackay Ran I. Mackay Karen J. Kirkby Karen J. Kirkby |
spellingShingle |
Nicholas T. Henthorn Nicholas T. Henthorn Olga Sokol Marco Durante Marco Durante Ludovic De Marzi Frederic Pouzoulet Justyna Miszczyk Pawel Olko Sytze Brandenburg Sytze Brandenburg Marc Jan van Goethem Marc Jan van Goethem Lara Barazzuol Lara Barazzuol Makbule Tambas Johannes A. Langendijk Marie Davídková Vladimír Vondráĉek Elisabeth Bodenstein Joerg Pawelke Joerg Pawelke Antony J. Lomax Antony J. Lomax Damien C. Weber Damien C. Weber Damien C. Weber Alexandru Dasu Alexandru Dasu Bo Stenerlöw Per R. Poulsen Brita S. Sørensen Cai Grau Mateusz K. Sitarz Anne-Catherine Heuskin Stephane Lucas John W. Warmenhoven John W. Warmenhoven Michael J. Merchant Michael J. Merchant Ran I. Mackay Ran I. Mackay Karen J. Kirkby Karen J. Kirkby Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project Frontiers in Physics proton therapy radiotherapy radiobiology beamline irradiation |
author_facet |
Nicholas T. Henthorn Nicholas T. Henthorn Olga Sokol Marco Durante Marco Durante Ludovic De Marzi Frederic Pouzoulet Justyna Miszczyk Pawel Olko Sytze Brandenburg Sytze Brandenburg Marc Jan van Goethem Marc Jan van Goethem Lara Barazzuol Lara Barazzuol Makbule Tambas Johannes A. Langendijk Marie Davídková Vladimír Vondráĉek Elisabeth Bodenstein Joerg Pawelke Joerg Pawelke Antony J. Lomax Antony J. Lomax Damien C. Weber Damien C. Weber Damien C. Weber Alexandru Dasu Alexandru Dasu Bo Stenerlöw Per R. Poulsen Brita S. Sørensen Cai Grau Mateusz K. Sitarz Anne-Catherine Heuskin Stephane Lucas John W. Warmenhoven John W. Warmenhoven Michael J. Merchant Michael J. Merchant Ran I. Mackay Ran I. Mackay Karen J. Kirkby Karen J. Kirkby |
author_sort |
Nicholas T. Henthorn |
title |
Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project |
title_short |
Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project |
title_full |
Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project |
title_fullStr |
Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project |
title_full_unstemmed |
Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project |
title_sort |
mapping the future of particle radiobiology in europe: the inspire project |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Physics |
issn |
2296-424X |
publishDate |
2020-10-01 |
description |
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The “Infrastructure in Proton International Research” (INSPIRE) project was created to provide an infrastructure for European research, unify research efforts on the topic of proton and ion therapy across Europe, and to facilitate the sharing of information and resources. This work highlights the radiobiological capabilities of the INSPIRE partners, providing details of physics (available particle types and energies), biology (sample preparation and post-irradiation analysis), and researcher access (the process of applying for beam time). The collection of information reported here is designed to provide researchers both in Europe and worldwide with the tools required to select the optimal center for their research needs. We also highlight areas of redundancy in capabilities and suggest areas for future investment. |
topic |
proton therapy radiotherapy radiobiology beamline irradiation |
url |
https://www.frontiersin.org/article/10.3389/fphy.2020.565055/full |
work_keys_str_mv |
AT nicholasthenthorn mappingthefutureofparticleradiobiologyineuropetheinspireproject AT nicholasthenthorn mappingthefutureofparticleradiobiologyineuropetheinspireproject AT olgasokol mappingthefutureofparticleradiobiologyineuropetheinspireproject AT marcodurante mappingthefutureofparticleradiobiologyineuropetheinspireproject AT marcodurante mappingthefutureofparticleradiobiologyineuropetheinspireproject AT ludovicdemarzi mappingthefutureofparticleradiobiologyineuropetheinspireproject AT fredericpouzoulet mappingthefutureofparticleradiobiologyineuropetheinspireproject AT justynamiszczyk mappingthefutureofparticleradiobiologyineuropetheinspireproject AT pawelolko mappingthefutureofparticleradiobiologyineuropetheinspireproject AT sytzebrandenburg mappingthefutureofparticleradiobiologyineuropetheinspireproject AT sytzebrandenburg mappingthefutureofparticleradiobiologyineuropetheinspireproject AT marcjanvangoethem mappingthefutureofparticleradiobiologyineuropetheinspireproject AT marcjanvangoethem mappingthefutureofparticleradiobiologyineuropetheinspireproject AT larabarazzuol mappingthefutureofparticleradiobiologyineuropetheinspireproject AT larabarazzuol mappingthefutureofparticleradiobiologyineuropetheinspireproject AT makbuletambas mappingthefutureofparticleradiobiologyineuropetheinspireproject AT johannesalangendijk mappingthefutureofparticleradiobiologyineuropetheinspireproject AT mariedavidkova mappingthefutureofparticleradiobiologyineuropetheinspireproject AT vladimirvondracek mappingthefutureofparticleradiobiologyineuropetheinspireproject AT elisabethbodenstein mappingthefutureofparticleradiobiologyineuropetheinspireproject AT joergpawelke mappingthefutureofparticleradiobiologyineuropetheinspireproject AT joergpawelke mappingthefutureofparticleradiobiologyineuropetheinspireproject AT antonyjlomax mappingthefutureofparticleradiobiologyineuropetheinspireproject AT antonyjlomax mappingthefutureofparticleradiobiologyineuropetheinspireproject AT damiencweber mappingthefutureofparticleradiobiologyineuropetheinspireproject AT damiencweber mappingthefutureofparticleradiobiologyineuropetheinspireproject AT damiencweber mappingthefutureofparticleradiobiologyineuropetheinspireproject AT alexandrudasu mappingthefutureofparticleradiobiologyineuropetheinspireproject AT alexandrudasu mappingthefutureofparticleradiobiologyineuropetheinspireproject AT bostenerlow mappingthefutureofparticleradiobiologyineuropetheinspireproject AT perrpoulsen mappingthefutureofparticleradiobiologyineuropetheinspireproject AT britassørensen mappingthefutureofparticleradiobiologyineuropetheinspireproject AT caigrau mappingthefutureofparticleradiobiologyineuropetheinspireproject AT mateuszksitarz mappingthefutureofparticleradiobiologyineuropetheinspireproject AT annecatherineheuskin mappingthefutureofparticleradiobiologyineuropetheinspireproject AT stephanelucas mappingthefutureofparticleradiobiologyineuropetheinspireproject AT johnwwarmenhoven mappingthefutureofparticleradiobiologyineuropetheinspireproject AT johnwwarmenhoven mappingthefutureofparticleradiobiologyineuropetheinspireproject AT michaeljmerchant mappingthefutureofparticleradiobiologyineuropetheinspireproject AT michaeljmerchant mappingthefutureofparticleradiobiologyineuropetheinspireproject AT ranimackay mappingthefutureofparticleradiobiologyineuropetheinspireproject AT ranimackay mappingthefutureofparticleradiobiologyineuropetheinspireproject AT karenjkirkby mappingthefutureofparticleradiobiologyineuropetheinspireproject AT karenjkirkby mappingthefutureofparticleradiobiologyineuropetheinspireproject |
_version_ |
1724470520500453376 |
spelling |
doaj-88275246ca1f4bacb94b8d81b66f30772020-11-25T03:55:09ZengFrontiers Media S.A.Frontiers in Physics2296-424X2020-10-01810.3389/fphy.2020.565055565055Mapping the Future of Particle Radiobiology in Europe: The INSPIRE ProjectNicholas T. Henthorn0Nicholas T. Henthorn1Olga Sokol2Marco Durante3Marco Durante4Ludovic De Marzi5Frederic Pouzoulet6Justyna Miszczyk7Pawel Olko8Sytze Brandenburg9Sytze Brandenburg10Marc Jan van Goethem11Marc Jan van Goethem12Lara Barazzuol13Lara Barazzuol14Makbule Tambas15Johannes A. Langendijk16Marie Davídková17Vladimír Vondráĉek18Elisabeth Bodenstein19Joerg Pawelke20Joerg Pawelke21Antony J. Lomax22Antony J. Lomax23Damien C. Weber24Damien C. Weber25Damien C. Weber26Alexandru Dasu27Alexandru Dasu28Bo Stenerlöw29Per R. Poulsen30Brita S. Sørensen31Cai Grau32Mateusz K. Sitarz33Anne-Catherine Heuskin34Stephane Lucas35John W. Warmenhoven36John W. Warmenhoven37Michael J. Merchant38Michael J. Merchant39Ran I. Mackay40Ran I. Mackay41Karen J. Kirkby42Karen J. Kirkby43Division of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United KingdomManchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United KingdomDepartment of Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, GermanyDepartment of Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, GermanyDepartment of Condensed Matter Physics, Technische Universität Darmstadt, Darmstadt, GermanyRadiation Oncology Department, Institut Curie, PSL Research University, Paris, FranceTranslational Research Department, Experimental Radiotherapy Platform, Institut Curie, PSL Research University, Orsay, FranceDepartment of Experimental Physics of Complex Systems, Institute of Nuclear Physics Polish Academy of Sciences, Krakow, PolandDepartment of Experimental Physics of Complex Systems, Institute of Nuclear Physics Polish Academy of Sciences, Krakow, PolandKVI-Center for Advanced Radiation Technology, University of Groningen, Groningen, NetherlandsDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsKVI-Center for Advanced Radiation Technology, University of Groningen, Groningen, NetherlandsDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands0Section of Molecular Cell Biology, Department of Biomedical Sciences of Cell and Systems, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands1Department of Radiation Dosimetry, Nuclear Physics Institute of the CAS, Prague, Czechia2Proton Therapy Center Czech, Prague, Czechia3OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden – Rossendorf, Technische Universität Dresden, Dresden, Germany3OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Helmholtz-Zentrum Dresden – Rossendorf, Technische Universität Dresden, Dresden, Germany4Helmholtz-Zentrum Dresden – Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany5Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland6Department of Physics, ETH, Zurich, Switzerland5Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland7Department of Radiation Oncology, University of Zurich, Zurich, Switzerland8Department of Radiation Oncology, University of Bern, Bern, Switzerland9The Skandion Clinic, Uppsala, Sweden0Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden0Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden1Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark1Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark1Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark1Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark2LARN-Laboratory, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium2LARN-Laboratory, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, BelgiumDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United KingdomManchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United KingdomDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United KingdomManchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United KingdomDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United Kingdom3Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, United KingdomDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, The University of Manchester, Manchester, United KingdomManchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, United KingdomParticle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The “Infrastructure in Proton International Research” (INSPIRE) project was created to provide an infrastructure for European research, unify research efforts on the topic of proton and ion therapy across Europe, and to facilitate the sharing of information and resources. This work highlights the radiobiological capabilities of the INSPIRE partners, providing details of physics (available particle types and energies), biology (sample preparation and post-irradiation analysis), and researcher access (the process of applying for beam time). The collection of information reported here is designed to provide researchers both in Europe and worldwide with the tools required to select the optimal center for their research needs. We also highlight areas of redundancy in capabilities and suggest areas for future investment.https://www.frontiersin.org/article/10.3389/fphy.2020.565055/fullproton therapyradiotherapyradiobiologybeamlineirradiation |